Richmond Pharmacology Appoints Patrick Ramiah as Director of Clinical Project Delivery & Operational Excellence

Richmond Pharmacology is delighted to announce the promotion of Patrick Ramiah to the role of Director of Clinical Project Delivery & Operational Excellence, effective from 1 September 2025. This appointment honours Patrick’s outstanding track record in advancing operational efficiency and delivering excellence across clinical project delivery.

Patrick joined Richmond in 2023 and has since become a driving force in optimising process performance, fostering continuous improvement culture, and embedding operational excellence across our organisation and project delivery teams. His strategic insights and leadership have consistently advanced our ability to deliver clinical trials with precision, efficiency, and robustness.

‍

_{Patrick Ramiah commented:
“I’m honoured to step into the role of Director of Clinical Project Delivery & Operational Excellence. In my time at Richmond, I’ve been inspired by our collective commitment to embracing continuous improvement as our working culture in delivering outstanding clinical research. I look forward to leading initiatives that elevate our operational standards, establishing robust processes, enhance delivery excellence, and ultimately ensure our trials continue to uphold participant safety and data integrity.”}

‍

_{Chief Medical Director, Dr Ulrike Lorch, added:
“Patrick’s promotion reflects the tangible impact he’s made since joining Richmond. His practical approach to operational excellence and his ability to drive collaboration across teams have strengthened how we implement clinical trials—especially as we navigate an increasingly complex research landscape. In this new role, Patrick will lead multidisciplinary teams in bridging the gap between governance and practical implementation, ensuring our trials are delivered compliantly, effectively, and with operational clarity.”}

‍

Patrick’s appointment highlights the importance of strong operational leadership in clinical research. His expertise will be key to shaping robust processes, driving innovation, and ensuring Richmond continues to deliver excellence in clinical trial delivery.

‍